-
1
-
-
80053289163
-
Toll-like receptors are key players in neurodegeneration
-
Arroyo D.S., Soria J.A., Gaviglio E.A., Rodriguez-Galan M.C., Iribarren P. Toll-like receptors are key players in neurodegeneration. Int. Immunopharmacol. 2007, 11(10):1415-1421.
-
(2007)
Int. Immunopharmacol.
, vol.11
, Issue.10
, pp. 1415-1421
-
-
Arroyo, D.S.1
Soria, J.A.2
Gaviglio, E.A.3
Rodriguez-Galan, M.C.4
Iribarren, P.5
-
2
-
-
51349083634
-
The heat shock protein 90 chaperone complex: an evolving therapeutic target
-
Barginear M.F., Van Poznak C., Rosen N., Modi S., Hudis C.A., Budman D.R. The heat shock protein 90 chaperone complex: an evolving therapeutic target. Curr. Cancer Drug Targets 2008, 8(6):522-532.
-
(2008)
Curr. Cancer Drug Targets
, vol.8
, Issue.6
, pp. 522-532
-
-
Barginear, M.F.1
Van Poznak, C.2
Rosen, N.3
Modi, S.4
Hudis, C.A.5
Budman, D.R.6
-
3
-
-
67651160909
-
Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma
-
Breinig M., Caldas-Lopes E., Goeppert B., Malz M., Rieker R., Bergmann F., Schirmacher P., Mayer M., Chiosis G., Kern M.A. Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma. Hepatology 2009, 50(1):102-112.
-
(2009)
Hepatology
, vol.50
, Issue.1
, pp. 102-112
-
-
Breinig, M.1
Caldas-Lopes, E.2
Goeppert, B.3
Malz, M.4
Rieker, R.5
Bergmann, F.6
Schirmacher, P.7
Mayer, M.8
Chiosis, G.9
Kern, M.A.10
-
4
-
-
66249138886
-
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
-
Caldas-Lopes E., Cerchietti L., Ahn J.H., Clement C.C., Robles A.I., Rodina A., Moulick K., Taldone T., Gozman A., Guo Y., Wu N., de Stanchina E., White J., Gross S.S., Ma Y., Varticovski L., Melnick A., Chiosis G. Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(20):8368-8373.
-
(2009)
Proc. Natl. Acad. Sci. U. S. A.
, vol.106
, Issue.20
, pp. 8368-8373
-
-
Caldas-Lopes, E.1
Cerchietti, L.2
Ahn, J.H.3
Clement, C.C.4
Robles, A.I.5
Rodina, A.6
Moulick, K.7
Taldone, T.8
Gozman, A.9
Guo, Y.10
Wu, N.11
de Stanchina, E.12
White, J.13
Gross, S.S.14
Ma, Y.15
Varticovski, L.16
Melnick, A.17
Chiosis, G.18
-
5
-
-
71549121697
-
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
-
Cerchietti L.C., Lopes E.C., Yang S.N., Hatzi K., Bunting K.L., Tsikitas L.A., Mallik A., Robles A.I., Walling J., Varticovski L., Shaknovich R., Bhalla K.N., Chiosis G., Melnick A. A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas. Nat. Med. 2009, 15(12):1369-1376.
-
(2009)
Nat. Med.
, vol.15
, Issue.12
, pp. 1369-1376
-
-
Cerchietti, L.C.1
Lopes, E.C.2
Yang, S.N.3
Hatzi, K.4
Bunting, K.L.5
Tsikitas, L.A.6
Mallik, A.7
Robles, A.I.8
Walling, J.9
Varticovski, L.10
Shaknovich, R.11
Bhalla, K.N.12
Chiosis, G.13
Melnick, A.14
-
6
-
-
33746365169
-
Discovery and development of purine-scaffold Hsp90 inhibitors
-
Chiosis G. Discovery and development of purine-scaffold Hsp90 inhibitors. Curr. Top. Med. Chem. 2006, 6(11):1183-1191.
-
(2006)
Curr. Top. Med. Chem.
, vol.6
, Issue.11
, pp. 1183-1191
-
-
Chiosis, G.1
-
7
-
-
0141485327
-
Development of purine-scaffold small molecule inhibitors of Hsp90
-
Chiosis G., Lucas B., Huezo H., Solit D., Basso A., Rosen N. Development of purine-scaffold small molecule inhibitors of Hsp90. Curr. Cancer Drug Targets 2003, 3(5):371-376.
-
(2003)
Curr. Cancer Drug Targets
, vol.3
, Issue.5
, pp. 371-376
-
-
Chiosis, G.1
Lucas, B.2
Huezo, H.3
Solit, D.4
Basso, A.5
Rosen, N.6
-
8
-
-
4744350064
-
Hsp90: the vulnerable chaperone
-
Chiosis G., Vilenchik M., Kim J., Solit D. Hsp90: the vulnerable chaperone. Drug Discov. Today 2004, 9(20):881-888.
-
(2004)
Drug Discov. Today
, vol.9
, Issue.20
, pp. 881-888
-
-
Chiosis, G.1
Vilenchik, M.2
Kim, J.3
Solit, D.4
-
9
-
-
80053300497
-
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
-
Constantinescu C.S., Farooqi N., O'Brien K., Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 2011, 164(4):1079-1106.
-
(2011)
Br. J. Pharmacol.
, vol.164
, Issue.4
, pp. 1079-1106
-
-
Constantinescu, C.S.1
Farooqi, N.2
O'Brien, K.3
Gran, B.4
-
10
-
-
33750945303
-
The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis
-
Dello Russo C., Polak P.E., Mercado P.R., Spagnolo A., Sharp A., Murphy P., Kamal A., Burrows F.J., Fritz L.C., Feinstein D.L. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J. Neurochem. 2006, 99(5):1351-1362.
-
(2006)
J. Neurochem.
, vol.99
, Issue.5
, pp. 1351-1362
-
-
Dello Russo, C.1
Polak, P.E.2
Mercado, P.R.3
Spagnolo, A.4
Sharp, A.5
Murphy, P.6
Kamal, A.7
Burrows, F.J.8
Fritz, L.C.9
Feinstein, D.L.10
-
11
-
-
69549139978
-
Involvement of mTOR kinase in cytokine dependent microglial activation and cell proliferation
-
Dello Russo C., Lisi L., Tringali G., Navarra P. Involvement of mTOR kinase in cytokine dependent microglial activation and cell proliferation. Biochem. Pharmacol. 2009, 78(9):1242-1251.
-
(2009)
Biochem. Pharmacol.
, vol.78
, Issue.9
, pp. 1242-1251
-
-
Dello Russo, C.1
Lisi, L.2
Tringali, G.3
Navarra, P.4
-
12
-
-
0036260784
-
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis
-
Feinstein D.L., Galea E., Gavrilyuk V., Brosnan C.F., Whitacre C.C., Dumitrescu-Ozimek L., Landreth G.E., Pershadsingh H.A., Weinberg G., Heneka M.T. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 2002, 51(6):694-702.
-
(2002)
Ann. Neurol.
, vol.51
, Issue.6
, pp. 694-702
-
-
Feinstein, D.L.1
Galea, E.2
Gavrilyuk, V.3
Brosnan, C.F.4
Whitacre, C.C.5
Dumitrescu-Ozimek, L.6
Landreth, G.E.7
Pershadsingh, H.A.8
Weinberg, G.9
Heneka, M.T.10
-
13
-
-
77956536780
-
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
-
Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010, 162(1):1-11.
-
(2010)
Clin. Exp. Immunol.
, vol.162
, Issue.1
, pp. 1-11
-
-
Fletcher, J.M.1
Lalor, S.J.2
Sweeney, C.M.3
Tubridy, N.4
Mills, K.H.5
-
14
-
-
0029664477
-
CD14 mediate endotoxin induction of nitric oxide synthase in cultured brain glial cells
-
Galea E., Reis D.J., Fox E.S., Xu H., Feinstein D.L. CD14 mediate endotoxin induction of nitric oxide synthase in cultured brain glial cells. J. Neuroimmunol. 1996, 64(1):19-28.
-
(1996)
J. Neuroimmunol.
, vol.64
, Issue.1
, pp. 19-28
-
-
Galea, E.1
Reis, D.J.2
Fox, E.S.3
Xu, H.4
Feinstein, D.L.5
-
15
-
-
0037119385
-
Norepinephrine increases I kappa B alpha expression in astrocytes
-
Gavrilyuk V., Dello Russo C., Heneka M.T., Pelligrino D., Weinberg G., Feinstein D.L. Norepinephrine increases I kappa B alpha expression in astrocytes. J. Biol. Chem. 2002, 277(33):29662-29668.
-
(2002)
J. Biol. Chem.
, vol.277
, Issue.33
, pp. 29662-29668
-
-
Gavrilyuk, V.1
Dello Russo, C.2
Heneka, M.T.3
Pelligrino, D.4
Weinberg, G.5
Feinstein, D.L.6
-
16
-
-
30444447639
-
Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90
-
He H., Zatorska D., Kim J., Aguirre J., Llauger L., She Y., Wu N., Immormino R.M., Gewirth D.T., Chiosis G. Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90. J. Med. Chem. 2006, 49(1):381-390.
-
(2006)
J. Med. Chem.
, vol.49
, Issue.1
, pp. 381-390
-
-
He, H.1
Zatorska, D.2
Kim, J.3
Aguirre, J.4
Llauger, L.5
She, Y.6
Wu, N.7
Immormino, R.M.8
Gewirth, D.T.9
Chiosis, G.10
-
17
-
-
0034070515
-
The heat shock response inhibits NF-kappaB activation, nitric oxide synthase type 2 expression, and macrophage/microglial activation in brain
-
Heneka M.T., Sharp A., Klockgether T., Gavrilyuk V., Feinstein D.L. The heat shock response inhibits NF-kappaB activation, nitric oxide synthase type 2 expression, and macrophage/microglial activation in brain. J. Cereb. Blood Flow Metab. 2000, 20(5):800-811.
-
(2000)
J. Cereb. Blood Flow Metab.
, vol.20
, Issue.5
, pp. 800-811
-
-
Heneka, M.T.1
Sharp, A.2
Klockgether, T.3
Gavrilyuk, V.4
Feinstein, D.L.5
-
18
-
-
0035048111
-
The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice
-
Heneka M.T., Sharp A., Murphy P., Lyons J.A., Dumitrescu L., Feinstein D.L. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice. J. Neurochem. 2001, 77(2):568-579.
-
(2001)
J. Neurochem.
, vol.77
, Issue.2
, pp. 568-579
-
-
Heneka, M.T.1
Sharp, A.2
Murphy, P.3
Lyons, J.A.4
Dumitrescu, L.5
Feinstein, D.L.6
-
19
-
-
74249085361
-
Update on Hsp90 inhibitors in clinical trial
-
Kim Y.S., Alarcon S.V., Lee S., Lee M.J., Giaccone G., Neckers L., Trepel J.B. Update on Hsp90 inhibitors in clinical trial. Curr. Top. Med. Chem. 2009, 9(15):1479-1492.
-
(2009)
Curr. Top. Med. Chem.
, vol.9
, Issue.15
, pp. 1479-1492
-
-
Kim, Y.S.1
Alarcon, S.V.2
Lee, S.3
Lee, M.J.4
Giaccone, G.5
Neckers, L.6
Trepel, J.B.7
-
20
-
-
78650777704
-
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
-
Lisi L., Navarra P., Feinstein D.L., Dello Russo C. The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. J. Neuroinflammation 2011, 8:1.
-
(2011)
J. Neuroinflammation
, vol.8
, pp. 1
-
-
Lisi, L.1
Navarra, P.2
Feinstein, D.L.3
Dello Russo, C.4
-
21
-
-
84856959528
-
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis
-
Lisi L., Navarra P., Cirocchi R., Sharp A., Stigliano E., Feinstein D.L., Dello Russo C. Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2012, 243(1-2):43-51.
-
(2012)
J. Neuroimmunol.
, vol.243
, Issue.1-2
, pp. 43-51
-
-
Lisi, L.1
Navarra, P.2
Cirocchi, R.3
Sharp, A.4
Stigliano, E.5
Feinstein, D.L.6
Dello Russo, C.7
-
22
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method
-
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25(4):402-408.
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
23
-
-
84857053558
-
The role of Hsp90 in protein complex assembly
-
Makhnevych T., Houry W.A. The role of Hsp90 in protein complex assembly. Biochim. Biophys. Acta 2012, 1823(3):674-682.
-
(2012)
Biochim. Biophys. Acta
, vol.1823
, Issue.3
, pp. 674-682
-
-
Makhnevych, T.1
Houry, W.A.2
-
24
-
-
0037083197
-
Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis
-
Murphy P., Sharp A., Shin J., Gavrilyuk V., Dello Russo C., Weinberg G., Sharp F.R., Lu A., Heneka M.T., Feinstein D.L. Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2002, 67(4):461-470.
-
(2002)
J. Neurosci. Res.
, vol.67
, Issue.4
, pp. 461-470
-
-
Murphy, P.1
Sharp, A.2
Shin, J.3
Gavrilyuk, V.4
Dello Russo, C.5
Weinberg, G.6
Sharp, F.R.7
Lu, A.8
Heneka, M.T.9
Feinstein, D.L.10
-
25
-
-
0037311069
-
Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of hsp90-based chaperones
-
Osawa Y., Lowe E.R., Everett A.C., Dunbar A.Y., Billecke S.S. Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of hsp90-based chaperones. J. Pharmacol. Exp. Ther. 2003, 304(2):493-497.
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.304
, Issue.2
, pp. 493-497
-
-
Osawa, Y.1
Lowe, E.R.2
Everett, A.C.3
Dunbar, A.Y.4
Billecke, S.S.5
-
26
-
-
41149111451
-
The Hsp90 molecular chaperone: an open and shut case for treatment
-
Pearl L.H., Prodromou C., Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 2008, 410(3):439-453.
-
(2008)
Biochem. J.
, vol.410
, Issue.3
, pp. 439-453
-
-
Pearl, L.H.1
Prodromou, C.2
Workman, P.3
-
27
-
-
0037320253
-
Molecular insights on the cerebral innate immune system
-
Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17(1):13-19.
-
(2003)
Brain Behav. Immun.
, vol.17
, Issue.1
, pp. 13-19
-
-
Rivest, S.1
-
28
-
-
0141767109
-
Identification of cis-regulatory regions necessary for robust Nos2 promoter activity in glial cells: indirect role for NF-κB
-
Sanchez A.C., Davis R.L., Syapin P.J. Identification of cis-regulatory regions necessary for robust Nos2 promoter activity in glial cells: indirect role for NF-κB. J. Neurochem. 2003, 86(6):1379-1390.
-
(2003)
J. Neurochem.
, vol.86
, Issue.6
, pp. 1379-1390
-
-
Sanchez, A.C.1
Davis, R.L.2
Syapin, P.J.3
-
29
-
-
50249159536
-
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
-
Sharp A.J., Polak P.E., Simonini V., Lin S.X., Richardson J.C., Bongarzone E.R., Feinstein D.L. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflammation 2008, 5:33.
-
(2008)
J. Neuroinflammation
, vol.5
, pp. 33
-
-
Sharp, A.J.1
Polak, P.E.2
Simonini, V.3
Lin, S.X.4
Richardson, J.C.5
Bongarzone, E.R.6
Feinstein, D.L.7
-
30
-
-
80054715606
-
The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis
-
Sosa R.A., Forsthuber T.G. The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Interferon Cytokine Res. 2011, 31(10):753-768.
-
(2011)
J. Interferon Cytokine Res.
, vol.31
, Issue.10
, pp. 753-768
-
-
Sosa, R.A.1
Forsthuber, T.G.2
-
31
-
-
0036690130
-
Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro
-
Vairano M., Dello Russo C., Pozzoli G., Battaglia A., Scambia G., Tringali G., Aloe-Spiriti M.A., Preziosi P., Navarra P. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur. J. Neurosci. 2002, 16(4):584-592.
-
(2002)
Eur. J. Neurosci.
, vol.16
, Issue.4
, pp. 584-592
-
-
Vairano, M.1
Dello Russo, C.2
Pozzoli, G.3
Battaglia, A.4
Scambia, G.5
Tringali, G.6
Aloe-Spiriti, M.A.7
Preziosi, P.8
Navarra, P.9
-
32
-
-
0141819958
-
The stress response: implications for the clinical development of hsp90 inhibitors
-
Whitesell L., Bagatell R., Falsey R. The stress response: implications for the clinical development of hsp90 inhibitors. Curr. Cancer Drug Targets 2003, 3(5):349-358.
-
(2003)
Curr. Cancer Drug Targets
, vol.3
, Issue.5
, pp. 349-358
-
-
Whitesell, L.1
Bagatell, R.2
Falsey, R.3
-
33
-
-
0141480200
-
Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase
-
Yoshida M., Xia Y. Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J. Biol. Chem. 2003, 278(38):36953-36958.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.38
, pp. 36953-36958
-
-
Yoshida, M.1
Xia, Y.2
-
34
-
-
4344674482
-
Targeting multiple signal transduction pathways through inhibition of Hsp90
-
Zhang H., Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J. Mol. Med. 2004, 82(8):488-499.
-
(2004)
J. Mol. Med.
, vol.82
, Issue.8
, pp. 488-499
-
-
Zhang, H.1
Burrows, F.2
-
35
-
-
84934439633
-
Molecular interaction network of the Hsp90 chaperone system
-
Zhao R., Houry W.A. Molecular interaction network of the Hsp90 chaperone system. Adv. Exp. Med. Biol. 2007, 594:27-36.
-
(2007)
Adv. Exp. Med. Biol.
, vol.594
, pp. 27-36
-
-
Zhao, R.1
Houry, W.A.2
|